Rab 3A Activators
Rab 3A activators represent a diverse array of chemicals that modulate vesicular trafficking processes and cellular dynamics, influencing the activation state of Rab 3A. Y-27632, a ROCK inhibitor, indirectly activates Rab 3A by disrupting actin cytoskeleton organization. The inhibition of ROCK alters cytoskeletal dynamics, creating conditions favorable for Rab 3A activation through modulation of vesicle transport. Similarly, Brefeldin A, a disruptor of ER-Golgi transport, indirectly activates Rab 3A by interfering with vesicular trafficking processes, potentially creating conditions conducive to Rab 3A activation. Actin cytoskeleton dynamics play a crucial role in vesicle transport, and several chemicals, including Latrunculin A, Cytochalasin D, Jasplakinolide, Latrunculin B, and Latrunculin C, impact Rab 3A activation indirectly by modulating actin filament polymerization. These chemicals disrupt actin cytoskeleton organization, influencing vesicular trafficking pathways and creating a cellular environment that can support Rab 3A activation.
Furthermore, NSC23766, a Rac1 inhibitor, indirectly activates Rab 3A by modulating cytoskeletal dynamics. Inhibition of Rac1 alters cellular processes such as migration and vesicle transport, indirectly contributing to Rab 3A activation by influencing the cellular context and pathways connected to Rab 3A function. Wortmannin, a PI3K inhibitor, indirectly influences Rab 3A by disrupting PI3K-mediated signaling, potentially impacting vesicle trafficking processes and creating conditions conducive to Rab 3A activation. Collectively, these diverse Rab 3A activators showcase the intricate network of cellular processes and signaling pathways through which Rab 3A function can be modulated. Understanding the specific biochemical and cellular mechanisms by which these chemicals act provides insights into the complex regulation of vesicular trafficking and the activation of Rab 3A in diverse cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK), a key regulator of the actin cytoskeleton. By inhibiting ROCK, Y-27632 influences cytoskeletal dynamics, potentially impacting vesicular trafficking processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a fungal metabolite that disrupts protein transport from the endoplasmic reticulum (ER) to the Golgi apparatus. By inhibiting the activity of the small GTPase ADP-ribosylation factor (ARF), Brefeldin A interferes with vesicular trafficking processes. The indirect activation of Rab 3A by Brefeldin A is mediated through the disruption of ER-Golgi transport, affecting the secretory pathway and potentially creating conditions favorable for Rab 3A activation. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D is a fungal metabolite that disrupts actin filament polymerization. By binding to the growing end of actin filaments, Cytochalasin D interferes with the actin cytoskeleton, potentially impacting vesicular trafficking processes. The indirect activation of Rab 3A by Cytochalasin D is mediated through the modulation of actin cytoskeleton dynamics, affecting vesicle transport and creating conditions conducive to Rab 3A activation. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small molecule inhibitor of dynamin, a GTPase involved in clathrin-mediated endocytosis. By inhibiting dynamin, Dynasore interferes with the endocytic pathway and vesicle trafficking processes. The indirect activation of Rab 3A by Dynasore is mediated through the disruption of clathrin-mediated endocytosis, affecting vesicle transport and creating conditions conducive to Rab 3A activation. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide is a natural product that stabilizes actin filaments and promotes actin polymerization. By enhancing actin dynamics, Jasplakinolide can influence vesicular trafficking processes. The indirect activation of Rab 3A by Jasplakinolide is mediated through the modulation of actin cytoskeleton organization, affecting vesicle transport and creating conditions conducive to Rab 3A activation. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $240.00 | 29 | |
Latrunculin B is a marine toxin that disrupts actin filament polymerization. By sequestering actin monomers, Latrunculin B interferes with the actin cytoskeleton, potentially impacting vesicular trafficking processes. The indirect activation of Rab 3A by Latrunculin B is mediated through the modulation of actin cytoskeleton dynamics, affecting vesicle transport and creating conditions conducive to Rab 3A activation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that indirectly influences Rab 3A through the modulation of the PI3K signaling pathway. By inhibiting PI3K, wortmannin disrupts downstream signaling events, potentially impacting vesicle trafficking processes. The indirect activation of Rab 3A by Wortmannin is mediated through the disruption of PI3K-mediated signaling, affecting vesicle transport and creating conditions conducive to Rab 3A activation. | ||||||